ITOS
Price
$9.83
Change
-$0.30 (-2.96%)
Updated
Dec 7, 3:14 PM EST
104 days until earnings call
VSTM
Price
$7.55
Change
+$0.14 (+1.89%)
Updated
Dec 7, 3:56 PM EST
Ad is loading...

Compare trend and price ITOS vs VSTM

Header iconITOS vs VSTM Comparison
Open Charts ITOS vs VSTMBanner chart's image
iTeos Therapeutics
Price$9.83
Change-$0.30 (-2.96%)
Volume$1K
CapitalizationN/A
Verastem
Price$7.55
Change+$0.14 (+1.89%)
Volume$105
CapitalizationN/A
View a ticker or compare two or three
ITOS vs VSTM Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ITOS vs. VSTM commentary
Dec 08, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a Buy and VSTM is a StrongBuy.

COMPARISON
Comparison
Dec 08, 2023
Stock price -- (ITOS: $10.11 vs. VSTM: $7.34)
Brand notoriety: ITOS and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 51% vs. VSTM: 86%
Market capitalization -- ITOS: $329.94M vs. VSTM: $165.5M
ITOS [@Biotechnology] is valued at $329.94M. VSTM’s [@Biotechnology] market capitalization is $165.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, VSTM is a better buy in the long-term than ITOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 5 TA indicator(s) are bullish while VSTM’s TA Score has 5 bullish TA indicator(s).

  • ITOS’s TA Score: 5 bullish, 3 bearish.
  • VSTM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ITOS is a better buy in the short-term than VSTM.

Price Growth

ITOS (@Biotechnology) experienced а +4.23% price change this week, while VSTM (@Biotechnology) price change was +14.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.16%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was +25.31%.

Reported Earning Dates

ITOS is expected to report earnings on Mar 20, 2024.

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (+6.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ITOS with price predictions.
OPEN
A.I.dvisor published
a Summary for VSTM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ITOS($330M) has a higher market cap than VSTM($166M). VSTM YTD gains are higher at: 51.967 vs. ITOS (-48.233). VSTM has higher annual earnings (EBITDA): -73.06M vs. ITOS (-87.99M). ITOS has more cash in the bank: 599M vs. VSTM (166M). ITOS has less debt than VSTM: ITOS (5.93M) vs VSTM (42M). ITOS has higher revenues than VSTM: ITOS (66.5M) vs VSTM (0).
ITOSVSTMITOS / VSTM
Capitalization330M166M199%
EBITDA-87.99M-73.06M120%
Gain YTD-48.23351.967-93%
P/E Ratio41.49N/A-
Revenue66.5M0-
Total Cash599M166M361%
Total Debt5.93M42M14%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOSVSTM
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
79%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRSIX8.740.06
+0.69%
Brookfield Global Rnwbls & Sst Infrs I
RYSOX70.58N/A
N/A
Rydex S&P 500 A
FIVVX32.43-0.01
-0.03%
Delaware Opportunity R6
HFMRX28.02-0.16
-0.57%
Hartford MidCap R3
DREQX16.06-0.27
-1.65%
BNY Mellon Research Growth Z

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with RCUS. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
+2.74%
RCUS - ITOS
62%
Loosely correlated
+0.89%
VSTM - ITOS
47%
Loosely correlated
+1.38%
LABP - ITOS
42%
Loosely correlated
+2.77%
MDGL - ITOS
41%
Loosely correlated
+0.54%
BEAM - ITOS
41%
Loosely correlated
+1.49%
More